371. Estimating SARS-CoV-2 Seroprevalence from Spent Blood Samples, January–March 2021

BACKGROUND: Measuring SARS-CoV-2 antibody prevalence in spent samples at serial time points can determine seropositivity in a diverse pool of individuals to inform understanding of trends as vaccinations are implemented. METHODS: Blood samples collected for clinical testing and then discarded ("...

Descripción completa

Detalles Bibliográficos
Autores principales: Graciaa, Daniel, Verkerke, Hans, Guarner, Jeannette, Moldoveanu, Ana Maria, Cheedarla, Narayana, Arthur, Connie, Neish, Andrew, Auld, Sara, Campbell, Angie, Roback, John, Gandhi, Neel, Shah, Sarita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644628/
http://dx.doi.org/10.1093/ofid/ofab466.572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644628/
http://dx.doi.org/10.1093/ofid/ofab466.572

Ejemplares similares